What is the NOAEL for Dibenzothiophene?
Dibenzothiophene has 10 NOAEL studies in the database. The lowest reported value is 0 unitless. Source: NTP ICE endocrine.
Also known as: (1,1'-Biphenyl)-2,2'-diyl sulfide, Dibenzo(b,d)thiophene, EINECS 205-072-9, UNII-Z3D4AJ1R48, alpha-thiafluorene
CAS 132-65-0
Dibenzothiophene (CAS 132-65-0) is a chemical substance; key hazard signal: IARC Group 3. Key regulatory status: cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, IARC.
Dibenzothiophene is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H371, H311, H315, H331, H332, H400, H410).
CAS, identifiers, formula, and alternate names for the matched substance record.
Carcinogenic hazard classification from IARC monograph evaluations.
| Group | Meaning | Evaluated | Volume |
|---|---|---|---|
| Group 3 | Not classifiable | 2011 | 103 |
Industrial and product-use categories associated with this substance.
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 35.57 | uM | AC50 | - | - | NTP ICE endocrine |
| 34.64 | uM | ACC | - | - | NTP ICE endocrine |
| =1.04 | mg/kg bw/day | BMDL (10 HED) | oral | Rat | ToxValDB PPRTV (CPHEA) |
| Z3D4AJ1R48 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3 | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 3 | unitless | IARC group | - | - | NTP ICE cancer |
| 0 | unitless | Model Score | - | - | NTP ICE endocrine |
| 0.00373 | unitless | Model Score | - | - | NTP ICE endocrine |
| =3 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB HESS |
| =0.003 | mg/kg bw/day | RfD (provisional) | oral | Human | ToxValDB PPRTV (CPHEA) |
Showing 10 of 10 studies
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Dibenzothiophene has 10 NOAEL studies in the database. The lowest reported value is 0 unitless. Source: NTP ICE endocrine.
Dibenzothiophene is classified by IARC as Group 3 — not classifiable as to its carcinogenicity to humans (evaluated 2011). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.
Yes, Dibenzothiophene is also indexed as a cosmetic ingredient under the name Dibenzothiophene. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, IARC Monographs, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Dibenzothiophene is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H371, H311, H315, H331, H332, H400, H410).
Dibenzothiophene also appears in cosmetics, pharmaceutical databases.